Simone Friedrich | Head of Ab Discovery & Development
iOmx Therapeutics AG

Simone Friedrich is Head of Antibody Discovery and Development at iOmx Therapeutics, where she leads the discovery, engineering and development of the company's T cell engager and bispecific antibodies. With 10 years' experience in biologics drug discovery — from phage display to developability — she drives the antibody work behind iOmx's solid tumour TCE pipeline. She completed her PhD at the Institute for Clinical Neuroimmunology, LMU Munich, before joining iOmx in 2016.